BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3530927)

  • 1. [Disorders of thrombocyte function and/or endothelial cell damage as a cause of primary pulmonary hypertension?].
    Mlczoch J
    Herz; 1986 Aug; 11(4):191-6. PubMed ID: 3530927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombocyte-vascular wall interaction and coronary heart disease].
    Lüscher TF
    Schweiz Med Wochenschr; 1991 Dec; 121(51-52):1913-22. PubMed ID: 1763300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated platelet angiostatin and circulating endothelial microfragments in idiopathic pulmonary arterial hypertension: a preliminary study.
    Jurasz P; Ng D; Granton JT; Courtman DW; Stewart DJ
    Thromb Res; 2010 Jan; 125(1):53-60. PubMed ID: 19427678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells.
    Damås JK; Otterdal K; Yndestad A; Aass H; Solum NO; Frøland SS; Simonsen S; Aukrust P; Andreassen AK
    Circulation; 2004 Aug; 110(8):999-1005. PubMed ID: 15302794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endothelial dysfunction and coronary heart disease. Interaction of endothelium and thrombocytes].
    Vanhoutte PM
    Schweiz Rundsch Med Prax; 1993 Oct; 82(42):1161-6. PubMed ID: 8248687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis.
    Menter DG; Steinert BW; Sloane BF; Taylor JD; Honn KV
    Cancer Res; 1987 May; 47(9):2425-32. PubMed ID: 3552214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology of non-cardiogenic pulmonary hypertension].
    Mlczoch J
    Wien Klin Wochenschr; 1986 Nov; 98(21):726-8. PubMed ID: 3811365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium dysfunction in the coronary circulation.
    Lüscher TF; Noll G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet physiology. Advances in platelet reactivity. Review].
    Vizcaíno-Salazar G
    Invest Clin; 1994 Mar; 35(1):41-62. PubMed ID: 8054381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.
    Mikhail N; Fukuda N; Tremblay J; Hamet P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S64-74. PubMed ID: 7508064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current insights on the pathogenesis of pulmonary arterial hypertension.
    Perros F; Dorfmüller P; Humbert M
    Semin Respir Crit Care Med; 2005 Aug; 26(4):355-64. PubMed ID: 16121311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of platelets in the pulmonary circulation. A review.
    Mlczoch J
    Cor Vasa; 1985; 27(2-3):153-9. PubMed ID: 4028732
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary pulmonary hypertension].
    Winkler J
    Z Gesamte Inn Med; 1993 Nov; 48(11):555-62. PubMed ID: 8291274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets and endothelial cells.
    Siegel-Axel DI; Gawaz M
    Semin Thromb Hemost; 2007 Mar; 33(2):128-35. PubMed ID: 17340460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombogenic properties of the vessel and their inhibition].
    Cazenave JP; Klein-Soyer C; Beretz A
    Nouv Rev Fr Hematol (1978); 1982; 24(3):167-71. PubMed ID: 6752880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and molecular pathobiology of pulmonary arterial hypertension.
    Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelets in the pathophysiology of acute coronary syndrome.
    Massberg S; Schulz C; Gawaz M
    Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary pulmonary hypertension: recent advances.
    Rich S
    Herz; 1986 Aug; 11(4):197-206. PubMed ID: 3530928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.